🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Holly Geres

Holly Geres

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial”.

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

Trials(2022)10.1186/s13063-022-07047-5

N/A

1.4DataRank · unranked

64 citations

Maria Souli, Michael Billard, J Campbell, Douglas Conrad, Damon W. Ellison +20 more

Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial

Trials(2025)10.1186/s13063-025-09228-4

N/A

0.208DataRank · unranked

3 citations

Lauren Komarow, Yixuan Li, Qiuwen Wu, Lucia Sanchez-Gonzalez, Donald Mau +13 more

The Future Ain’t What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group Innovations

Clinical Infectious Diseases(2023)10.1093/cid/ciad538

N/A

0DataRank · unranked

13 citations

Robin Patel, Toshimitsu Hamasaki, Jessica Howard‐Anderson, Tori Kinamon, H. A. King +36 more

Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review

Clinical Infectious Diseases(2023)10.1093/cid/ciad565

N/A

0DataRank · unranked

6 citations

César A. Arias, Deena R. Altman, Ahmed Babiker, Helen W. Boucher, C. Buddy Creech +40 more

Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group

Clinical Infectious Diseases(2023)10.1093/cid/ciad529

N/A

0DataRank · unranked

2 citations

Kerryl E. Greenwood‐Quaintance, Maria Souli, Lauren Komarow, Holly Geres, Toshimitsu Hamasaki +6 more

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions

Clinical Infectious Diseases(2023)10.1093/cid/ciad475

N/A

0DataRank · unranked

9 citations

H. R. Cross, Maria Souli, Scott Evans, Robin Patel, Vance G. Fowler +60 more

Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Clinical Infectious Diseases(2023)10.1093/cid/ciad576

N/A

0DataRank · unranked

18 citations

Toshimitsu Hamasaki, Weixiao Dai, Deborah Collyar, Daniel B. Rubin, Sumathi Nambiar +24 more